Nonendemic HPV-Positive Nasopharyngeal Carcinoma: Association With Poor Prognosis

Journal Article · Sat Mar 01 00:00:00 EST 2014 · International Journal of Radiation Oncology, Biology and Physics

DOI:https://doi.org/10.1016/J.IJROBP.2013.11.246· OSTI ID:22416458

McHugh, Jonathan B. ^[1]; Schipper, Matthew ^[2]; Walline, Heather M.; Komarck, Christine ^[3]; Feng, Felix Y. ^[2]; Worden, Francis P. ^[4]; Wolf, Gregory T.; Chepeha, Douglas B.; Prince, Mark E.; Bradford, Carol R. ^[3]; Mukherji, Suresh K. ^[5]; Eisbruch, Avraham ^[2]; Carey, Thomas E. ^[3]

---

1. Department of Pathology, University of Michigan Medical Center, Ann Arbor, Michigan (United States)
2. Department of Radiation Oncology, University of Michigan Medical Center, Ann Arbor, Michigan (United States)
3. Department of Head and Neck Surgery, University of Michigan Medical Center, Ann Arbor, Michigan (United States)
4. Department of Medical Oncology, University of Michigan Medical Center, Ann Arbor, Michigan (United States)
5. Department of Radiology, University of Michigan Medical Center, Ann Arbor, Michigan (United States)

Purpose: To investigate the relationship between human papillomavirus (HPV) and Epstein-Barr virus (EBV) in nonendemic nasopharyngeal carcinoma (NPC) and assess the prognostic implications of viral status. Methods and Materials: Paraffin-embedded tumor specimens from 62 patients with primary NPC diagnosed between 1985 and 2011 were analyzed for EBV and high-risk HPV. EBV status was determined by the use of in situ hybridization for EBV encoded RNA. HPV status was assessed with p16 immunohistochemistry and multiplex polymerase chain reaction MassArray for determination of HPV type. Proportional hazards models were used to compare the risk of death among patients as stratified by viral status. Results: Of 61 evaluable tumors, 26 (43%) were EBV-positive/HPV-negative, 18 (30%) were HPV-positive/EBV-negative, and 17 (28%) were EBV/HPV-negative. EBV and HPV infection was mutually exclusive. HPV positivity was significantly correlated with World Health Organization grade 2 tumors, older age, and smoking (all P<.001). The racial distribution of the study population was 74% white, 15% African American, and 11% Asian/Middle Eastern. Among HPV-positive patients, 94% were white. At a median follow-up time of 7 years, HPV-positive and EBV/HPV-negative tumors exhibited worse outcomes than did EBV-positive tumors, including decreased overall survival (hazard ratio [HR] 2.98, P=.01; and HR 3.89, P=.002), progression-free survival (HR 2.55, P=.02; and HR 4.04, P<.001), and locoregional control (HR 4.01, P=.03; and HR 6.87, P=.001). Conclusion: In our Midwestern population, high-risk HPV infection may play an etiologic role in the development of nonendemic, EBV-negative NPC. Compared with EBV-positive NPC, HPV-positive and EBV/HPV-negative NPC are associated with worse outcomes. A larger confirmatory study is needed to validate these findings.

• OSTI ID: 22416458
• Journal Information: International Journal of Radiation Oncology, Biology and Physics, Vol. 88, Issue 3; Other Information: Copyright (c) 2014 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.; Country of input: International Atomic Energy Agency (IAEA); ISSN 0360-3016
• Country of Publication: United States
• Language: English

Related Subjects

62 RADIOLOGY AND NUCLEAR MEDICINE
CARCINOMAS
COMPARATIVE EVALUATIONS
DIAGNOSIS
HAZARDS
IN-SITU HYBRIDIZATION
ONCOGENIC VIRUSES
PATIENTS
RNA